Ginkgo Bioworks focuses on its Foundry and Code Base assets to offer R&D services and drive down costs for clients. The company secures a significant deal with Pfizer in the drug discovery category, ...

Ginkgo Bioworks (NYSE:DNA) stock has been downgraded to sell by Goldman Sachs over concerns about weakening end-market demand in the biopharma market. Goldman Sachs said in a note dated June 2 that it ...

Ginkgo Bioworks said it would lay off more than one-third of its workers as the Boston life sciences firm slashes costs in the face of plunging revenues. The company, which specializes in cell ...

Ginkgo Bioworks is cutting costs and laying off staff after losing $166 million in the first quarter. Revenue from its disease-monitoring business surged during the COVID-19 pandemic but was down more ...

Customizable, anaerobic-enabled system aims to accelerate discovery and development of sustainable biofuels at the University of Wisconsin–Madison's GLBRC GLBRC's mission involves numerous ...

Ginkgo Bioworks (NYSE: DNA) today announced its partnership with Carnegie-Mellon University (CMU) for an award by the Advanced Research Projects Agency for Health (ARPA-H) for its POSEIDON program ...

Removing a certain gnarled ash tree in Farragut Square has become something of a chore for the National Park Service, which oversees the downtown park. Earlier this week, the mistaken removal of a 140 ...

The popular herb ginkgo biloba does not reduce the risk of dementia or Alzheimer's disease, according to a study of more than 1,500 elderly patients who took the supplement. Often touted as a way to ...

(MENAFN- PR Newswire) GLBRC's mission involves numerous investigators tackling a variety of scientific challenges, requiring flexible and robust research infrastructure. The anaerobic-capable ...

Customizable, anaerobic-enabled system aims to accelerate discovery and development of sustainable biofuels at the University of Wisconsin–Madison's GLBRC BOSTON, Jan. 23, 2025 /PRNewswire/ -- Ginkgo ...